Fidelity International’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.61M Buy
15,760
+3,929
+33% +$1.04M 0.01% 632
2026
Q1
$1.3M Sell
11,831
-1,264
-10% -$180K ﹤0.01% 813
2025
Q4
$2.18M Buy
+13,095
New +$2.19M ﹤0.01% 764
2024
Q2
Sell
-5,782
Closed -$429K 969
2024
Q1
$429K Buy
+5,782
New +$428K ﹤0.01% 770

Other funds holding ALAB

Fidelity International's ALAB Position: Q2 2026 in Review

Fidelity International increased its Astera Labs (ALAB) stake by 33% in Q2 2026, buying an estimated $1.04M and bringing the position to 15,760 shares worth $7.61M. The position accounts for 0.01% of the portfolio, ranked #632.

Fidelity International first reported a position in ALAB in Q1 2024 and has held it in 4 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Fidelity International held 15,760 shares of Astera Labs worth $7.61M as of Q2 2026.
  • Fidelity International bought 3,929 Astera Labs shares in Q2 2026, an estimated $1.04M.
  • Astera Labs made up 0.01% of Fidelity International's portfolio in Q2 2026, its #632 holding.
  • Fidelity International first reported a position in Astera Labs in Q1 2024 and has held it in 4 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.